Johnson & Johnson (JNJ.xnys) is an American multinational corporation founded in 1886 and headquartered in New Jersey, the United States. Johnson & Johnson focuses on the development and sales of medical devices, pharmaceuticals, and consumer packaged goods. It is the fourth-largest pharmaceutical company globally, consisting of about 250 subsidiary companies, a workforce of 130.000 people, operations in 60 countries, and products sold in over 175 countries. Johnson & Johnson (JNJ.xnys) is traded on the New York Stock Exchange (NYSE) as a component of the Dow Jones Industrial Average Index (DJIA), the Standard & Poor’s 500 (S&P-500), the Standard & Poor’s 100 (S&P-100), and has a market cap of $455.08B (USD). Johnson & Johnson committed over $1B (USD) toward the development of a not-for-profit COVID-19 vaccine. However, the company announced a 27.14% increase for the quarter and a 10.79% increase for the twelve months ending June 2021. It faces 26.000 new lawsuits over its baby powder allegations for causing ovarian cancer.
Johnson & Johnson (JNJ)
Explore Johnson & Johnson (JNJ) share price, news, and insights for effective trading. Stay informed with FP Markets Hong Kong.